Advancing Science Through Research

At Bristol-Myers Squibb, we stand on the frontier of new possibilities regarding patient care. New medicines. New delivery systems. New hope.

The potential is real. The opportunities are endless.

Since late 2002, our R&D team has helped to bring to patients many new medicines to treat cancer, serious mental illness, HIV/AIDS, hepatitis B, rheumatoid arthritis, cardiovascular disease, organ transplant and diabetes. While our focus continues in many of these areas, we are also expanding our efforts to other diseases where the science beckons and the patient need is evident.

Our R&D strategy is to pursue significant areas of unmet medical need by leveraging our legacy in discovering and developing small molecules as well as our growing experience and expertise in biologic proteins.

As we look ahead to the future, our focus remains on building a pipeline of innovative therapies that expand the frontiers of biomedical research.

Most of all, our future depends on the people who work here. Each day, all around the world, we come to work committed to our Company mission: to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. This is our North Star.

Learn more here

LINKS TO RELATED RESOURCES: 

https://www.workingtogetherforpatients.com/https://www.youtube.com/channel/UCjFf4oKibYrHae2NZ_GPS6g

Join Bristol-Myers Squibb Online:

Website: http://www.bms.com

Twitter: http://www.twitter.com/BMSnews

LinkedIn: https://www.linkedin.com/company/bristol-myers-squibb

YouTube: https://www.youtube.com/channel/UCjFf4oKibYrHae2NZ_GPS6g

Content from this campaign

Diversity & Inclusion

The Robert A. Winn Diversity in Clinical Trials Award Program Established by the Bristol Myers Squibb Foundation To Expand With Amgen’s Commitment of $8 Million
The Robert A. Winn Diversity in Clinical Trials Award Program (Winn Award Program) established by the Bristol Myers Squibb Foundation (BMSF) announced that Amgen, a global biotechnology company, has committed to contribute $8 million over the next four years.

Awards, Ratings & Rankings

The Robert A. Winn Diversity in Clinical Trials Award Program Announces the Second Group of Physicians to be Trained in the $114 Million Program
The Bristol Myers Squibb Foundation (BMSF) announced that an additional 64 physicians have been selected to receive the Robert A. Winn Diversity in Clinical Trials Career Development Award (Winn CDA).

Diversity & Inclusion

Dreaming Big and Trusting in Talent: Getting To Know John Loveseth
Meet John Loveseth, the global lead for CLIMB (Cultivating Leadership in Millennials and Beyond), one of our eight People & Business Resource Groups (PBRGs) at Bristol Myers Squibb.

Diversity & Inclusion

Voices From R&D: Personal Experience Inspires the Development of New Medicines
We encourage all colleagues to bring their authentic selves to work, and we believe diverse thinking and a collaborative culture can help spark innovation.

Health & Healthcare

From Numbers to Knowledge: Unlocking the Predictive Power of Data To Accelerate Transformative Science
Scientists and experts at Bristol Myers Squibb are working to revolutionize the process of drug development with sophisticated scientific strategies driven by technology.

Health & Healthcare

Today's Cell Therapy Insights Shaping Tomorrow
While cancer remains one of the greatest global health challenges, there have been unprecedented breakthroughs and innovations in cancer research in recent years, and more people are living longer with cancer than ever before.

Health & Healthcare

The Evolution of Lung Cancer Research
Abderrahim Oukessou, MD, our vice president and Thoracic Cancers Development Lead, sat down with Adam Schoenfeld, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, to discuss how the landscape of lung cancer research has transformed in recent years.

Innovation & Technology

Unleashing Innovation Through Incubators and Beyond
Bristol Myers Squibb’s commitment to R&D innovation goes beyond its internal drug discovery engine and even beyond a vast network of external partnerships.

Diversity & Inclusion

Diversifying Clinical Trials: A Global Initiative With Local Roots
Increasing diversity in clinical trials (DiCT) is imperative to improve the health of populations around the world.

Research, Reports & Publications

Bristol-Myers Squibb Awards “Golden Tickets” for LabCentral to ReviveMed, Strand Therapeutics
Bristol-Myers Squibb Company and LabCentral, an innovative, shared laboratory space designed as a launchpad for life-sciences and biotech startups, today announced that ReviveMed and Strand Therapeutics are the winners of Bristol-Myers Squibb’s 2018 Golden Tickets for LabCentral. As a platinum sponsor of LabCentral, Bristol-Myers Squibb can select up to two innovative life-sciences and biotech startup companies per year of active sponsorship for “Golden Tickets,” which underwrite the cost of one lab bench for one year in LabCentral’s Kendall Square facility.

More from Bristol Myers Squibb Company

  1. Our Culture and Commitments
    At Bristol-Myers Squibb, our Mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are...
  2. Advancing Science Through Research
    At Bristol-Myers Squibb, we stand on the frontier of new possibilities regarding patient care. New medicines. New delivery systems. New hope.The...
  3. Bristol Myers Squibb Foundation
    The Bristol-Myers Squibb Foundation promotes health equity and seeks to improve the health outcomes of populations disproportionately affected by...
  4. Our Commitment to Sustainability
    At Bristol-Myers Squibb, sustainability means conducting our business to help patients prevail over serious diseases in a manner that contributes to...
  5. Working Together for Patients
    People and patients are at the center of everything we do at Bristol-Myers Squibb. When we ask employees who they work for, the answer is always: we...